Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Elevance Health, Inc. stock logo
ELV
Elevance Health
$416.87
+3.0%
$424.52
$362.21
$567.26
$91.41B0.661.47 million shs2.03 million shs
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
$103.82
+7.1%
$107.00
$62.07
$119.96
$129.27B0.267.62 million shs12.93 million shs
Medtronic plc stock logo
MDT
Medtronic
$85.70
+2.7%
$86.59
$75.96
$96.25
$109.91B0.816.73 million shs7.72 million shs
Stryker Co. stock logo
SYK
Stryker
$387.97
+1.9%
$365.31
$314.93
$406.19
$148.08B0.931.36 million shs1.36 million shs
7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Elevance Health, Inc. stock logo
ELV
Elevance Health
0.00%-1.27%-8.02%+2.06%-24.97%
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
0.00%-6.58%-6.53%+1.45%+46.85%
Medtronic plc stock logo
MDT
Medtronic
0.00%-1.50%+0.94%-8.11%+0.76%
Stryker Co. stock logo
SYK
Stryker
0.00%+0.60%+8.82%-2.88%+15.21%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Elevance Health, Inc. stock logo
ELV
Elevance Health
4.5718 of 5 stars
3.43.04.20.03.52.52.5
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
4.9172 of 5 stars
2.45.04.24.14.02.51.9
Medtronic plc stock logo
MDT
Medtronic
4.5397 of 5 stars
3.23.03.34.03.01.70.6
Stryker Co. stock logo
SYK
Stryker
4.8643 of 5 stars
3.43.03.34.23.92.51.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Elevance Health, Inc. stock logo
ELV
Elevance Health
2.76
Moderate Buy$510.3822.43% Upside
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
2.78
Moderate Buy$110.556.48% Upside
Medtronic plc stock logo
MDT
Medtronic
2.44
Hold$96.1412.19% Upside
Stryker Co. stock logo
SYK
Stryker
2.79
Moderate Buy$427.0510.07% Upside

Current Analyst Ratings Breakdown

Latest MDT, SYK, ELV, and GILD Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/5/2025
Stryker Co. stock logo
SYK
Stryker
Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price Target$450.00
5/5/2025
Stryker Co. stock logo
SYK
Stryker
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$390.00 ➝ $400.00
5/5/2025
Stryker Co. stock logo
SYK
Stryker
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Perform ➝ Market Perform
5/2/2025
Stryker Co. stock logo
SYK
Stryker
Roth Mkm
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$405.00 ➝ $456.00
5/2/2025
Stryker Co. stock logo
SYK
Stryker
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$400.00 ➝ $390.00
4/25/2025
Elevance Health, Inc. stock logo
ELV
Elevance Health
Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price Target$465.00
4/25/2025
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$130.00 ➝ $135.00
4/25/2025
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$132.00 ➝ $125.00
4/25/2025
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold ➝ Hold
4/23/2025
Elevance Health, Inc. stock logo
ELV
Elevance Health
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$478.00 ➝ $478.00
4/23/2025
Elevance Health, Inc. stock logo
ELV
Elevance Health
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$518.00 ➝ $518.00
(Data available from 5/12/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Elevance Health, Inc. stock logo
ELV
Elevance Health
$183.12B0.51$41.81 per share9.97$178.62 per share2.33
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
$28.74B4.50$8.20 per share12.66$15.44 per share6.72
Medtronic plc stock logo
MDT
Medtronic
$33.20B3.31$7.02 per share12.21$38.69 per share2.21
Stryker Co. stock logo
SYK
Stryker
$23.22B6.38$15.14 per share25.62$54.08 per share7.17
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Elevance Health, Inc. stock logo
ELV
Elevance Health
$5.98B$25.6316.2810.681.183.38%18.28%6.72%7/16/2025 (Estimated)
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
$480M$4.75280.5912.800.711.67%31.63%10.38%N/A
Medtronic plc stock logo
MDT
Medtronic
$3.68B$3.2926.0514.702.2212.83%14.07%7.70%5/21/2025 (Estimated)
Stryker Co. stock logo
SYK
Stryker
$2.99B$7.4050.0026.162.9313.25%23.58%11.37%7/29/2025 (Estimated)

Latest MDT, SYK, ELV, and GILD Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/21/2025Q4 2025
Medtronic plc stock logo
MDT
Medtronic
$1.58N/AN/AN/A$8.81 billionN/A
5/1/2025Q1 2025
Stryker Co. stock logo
SYK
Stryker
$2.73$2.84+$0.11$1.69$5.68 billion$5.87 billion
4/24/2025Q1 2025
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
$1.77$1.81+$0.04$1.04$6.77 billion$6.67 billion
4/22/2025Q1 2025
Elevance Health, Inc. stock logo
ELV
Elevance Health
$10.60$11.97+$1.37$9.61$46.26 billion$48.77 billion
2/18/2025Q3 2025
Medtronic plc stock logo
MDT
Medtronic
$1.36$1.39+$0.03$1.01$8.33 billion$8.29 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Elevance Health, Inc. stock logo
ELV
Elevance Health
$6.841.64%+12.99%26.69%14 Years
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
$3.163.04%+2.74%66.53%10 Years
Medtronic plc stock logo
MDT
Medtronic
$2.803.27%+4.14%85.11%48 Years
Stryker Co. stock logo
SYK
Stryker
$3.360.87%+7.82%45.41%32 Years

Latest MDT, SYK, ELV, and GILD Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/8/2025
Stryker Co. stock logo
SYK
Stryker
quarterly$0.840.88%6/30/20256/30/20257/31/2025
4/25/2025
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
quarterly$0.793%6/13/20256/13/20256/27/2025
4/23/2025
Elevance Health, Inc. stock logo
ELV
Elevance Health
quarterly$1.711.6%6/10/20256/10/20256/25/2025
3/6/2025
Medtronic plc stock logo
MDT
Medtronic
quarterly$0.703%3/28/20253/28/20254/11/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Elevance Health, Inc. stock logo
ELV
Elevance Health
0.71
1.45
1.50
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
1.24
1.50
1.20
Medtronic plc stock logo
MDT
Medtronic
0.48
1.90
1.39
Stryker Co. stock logo
SYK
Stryker
0.59
1.95
1.32

Institutional Ownership

CompanyInstitutional Ownership
Elevance Health, Inc. stock logo
ELV
Elevance Health
89.24%
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
83.67%
Medtronic plc stock logo
MDT
Medtronic
82.06%
Stryker Co. stock logo
SYK
Stryker
77.09%

Insider Ownership

CompanyInsider Ownership
Elevance Health, Inc. stock logo
ELV
Elevance Health
0.29%
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
0.27%
Medtronic plc stock logo
MDT
Medtronic
0.20%
Stryker Co. stock logo
SYK
Stryker
5.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
Elevance Health, Inc. stock logo
ELV
Elevance Health
102,300225.94 million231.11 millionOptionable
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
17,0001.25 billion1.24 billionOptionable
Medtronic plc stock logo
MDT
Medtronic
95,0001.28 billion1.28 billionOptionable
Stryker Co. stock logo
SYK
Stryker
51,000381.69 million359.07 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Elevance Health stock logo

Elevance Health NYSE:ELV

$416.87 +12.29 (+3.04%)
Closing price 03:59 PM Eastern
Extended Trading
$420.84 +3.98 (+0.95%)
As of 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits. The company operates in the pharmacy services business; and markets and offers pharmacy services, including pharmacy benefit management, as well as home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services. In addition, it provides healthcare-related services and capabilities, including utilization management, behavioral health, integrated care delivery, palliative care, payment integrity services, subrogation services, and health and wellness programs, as well as services related to data management, information technology, and business operations. Further, the company is involved in the National Government Services business. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brand names. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is headquartered in Indianapolis, Indiana.

Gilead Sciences stock logo

Gilead Sciences NASDAQ:GILD

$103.82 +6.91 (+7.13%)
Closing price 04:00 PM Eastern
Extended Trading
$103.51 -0.31 (-0.30%)
As of 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, and Trodelvy products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. The company has collaboration agreements with Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Arcellx, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company was incorporated in 1987 and is headquartered in Foster City, California.

Medtronic stock logo

Medtronic NYSE:MDT

$85.70 +2.22 (+2.66%)
Closing price 03:59 PM Eastern
Extended Trading
$84.96 -0.74 (-0.87%)
As of 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Stryker stock logo

Stryker NYSE:SYK

$387.97 +7.05 (+1.85%)
Closing price 03:59 PM Eastern
Extended Trading
$393.25 +5.28 (+1.36%)
As of 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.